ライフサイエンスコーパス: human herpes virus

1 d ex vivo human tonsillar tissue system) and human herpes viruses.

2 , and sequences of common pathogens, such as human herpes virus 1, can be demonstrated.

3 associated with smaller MS-HLA effect, with human herpes virus 3 (HHV3), JC human polyoma virus (JCV

4 been implicated in breast cancer, including human herpes virus 4 (HHV4), human herpes virus 5 (HHV5)

5 ncer, including human herpes virus 4 (HHV4), human herpes virus 5 (HHV5), human papilloma virus (HPV)

6 s (HCMV and MCMV), Epstein-Barr virus (EBV), human herpes virus 6 (HHV-6), varicella zoster virus (VZ

7 Adenovirus (OR, 2.67; 95% CI, 1.75-4.36) and human herpes virus 6 (OR, 3.50; 95% CI, 1.15-10.63) were

8 Subject 2 had respiratory failure, human herpes virus 6 infection, cytopenias, and no circu

9 samples comprised of genomic lambda-DNA and human herpes virus 6 type B (HHV-6B) DNA, we have used o

10 -human parechovirus, herpes simplex virus 2, human herpes virus 6, and varicella zoster virus-were >9

11 lar candidate, such as Epstein-Barr virus or human herpes virus 6.

12 is increasing evidence that the neurotropic human herpes viruses 6 and 7 (HHV-6, HHV-7) comprise a s

13 sequence identity to positional homologs in human herpes viruses 6 and 7.

14 (HSV II), varicella-zoster virus (VZV), and human herpes virus-6 (HHV-6) nucleic acid sequences.

15 or type 1/2 unspecified, cytomegalovirus and human herpes virus-6 measured by serum IgM, high titre I

16 -1 and HSV-2), varicella-zoster virus (VZV), human herpes virus-6, 7, and 8 (HHV-6, HHV-7, and HHV-8)

17 We detected human herpes virus 6B and 7, Epstein-Barr virus, and par

18 However, the patient had evidence of human herpes virus-6B infection.

19 puzzle as they relate to viral factors-both human herpes virus 8 (HHV-8) and human immunodeficiency

20 Human herpes virus 8 (HHV-8) is a geographically limited

21 Human herpes virus 8 (HHV-8) or Kaposi sarcoma-associate

22 Human herpes virus 8 (HHV-8), also known as Kaposi's sar

23 Kaposi sarcoma (KS), a human herpes virus 8 (HHV-8; also called KSHV)-induced e

24 osi's sarcoma-associated herpes virus (KSHV)/human herpes virus 8 (HHV8) DNA sequences have been demo

25 Infection with human herpes virus 8 (HHV8) has been associated with Kap

26 The human herpes virus 8 (HHV8)-encoded viral FLICE (Fas-ass

27 The human herpes virus 8 (HHV8)-encoded viral FLICE inhibito

28 sociated herpesvirus, which is also known as human herpes virus 8 (KSHV/ HHV8), has not been reported

29 Human T-cell leukemia virus 1 and human herpes virus 8 genomes are also found in tumor cel

30 A positivity; 14.9% (95% CI: 12.4-17.4%) for human herpes virus 8 infection.

31 osi's sarcoma (KS)-associated herpesvirus or human herpes virus 8 is considered the etiological agent

32 osi's sarcoma-associated herpes virus (KSHV)/human herpes virus 8 is oncogenic and stimulates angioge

33 The KS-associated herpesvirus/human herpes virus 8 open reading frame 74 encodes a con

34 -SP on Kaposi sarcoma-associated herpesvirus/human herpes virus 8 replication and uptake of the ORF45

35 ion are at increased risk for development of human herpes virus 8(HHV-8)-associated Kaposi's sarcoma

36 virus remains uncertain, a new herpes virus, human herpes virus 8, has been identified in the rare su

37 human chemokine homologue that is encoded by human herpes virus 8.

38 try of Kaposi sarcoma-associated herpesvirus/human herpes virus 8.

39 Human herpes virus-8 (HHV-8) drives the hypercytokinemia

40 These interactions were disrupted by an human herpes virus-8 (HHV-8)-coded oncoprotein, vIRF1, a

41 Human herpes virus-8 (HHV8) maintains infection, in part

42 which is divided into idiopathic MCD (iMCD), human herpes virus-8 (HHV8)-associated MCD (HHV8-MCD), a

43 Human herpes virus-8 and angiogenesis, both involved in

44 might happen following reciprocal actions of human herpes virus-8 infection, immunosuppression, and c

45 U immunity, vaccine-antibody production, and human herpes virus amplify this effect.

46 Retention of human herpes virus and tumor-associated antigen (TAA)-sp

47 D8+ immune responses to clinically important human herpes viruses and to the TAA WT1.

48 Sequential human herpes virus (HHV) reactivation is well known in d

49 mucosa-associated lymphoid tissue lymphoma, human herpes virus (HHV)-6, HHV-7, chlamydia, Epstein-Ba

50 Human herpes viruses (HHV) are ubiquitous and have been

51 screened possible pathogen(s) for detecting human herpes virus (HHV1-HHV7), HEV, or Mycoplasma pneum

52 1, DPB1*02:01) to > 10,000 antigens of the 9 Human Herpes Viruses (HHV1, HHV2, HHV3, HHV4, HHV5, HHV6

53 Several viruses including human herpes viruses (HHVs), human polyomavirus JCV, and

54 Human herpes virus infection was similar between HEU and

55 Epstein-Barr virus (EBV), a human herpes virus, is associated with a variety of mali

56 MV, herpes simplex virus type 1 (HSV-1), and human herpes virus six (HHV-6) and for cytotoxicity.

57 Epstein-Barr virus (EBV) is a human herpes virus that infects >90% of individuals.

58 virus (HCV), human papillomavirus (HPV), and human herpes viruses, this paradigm is not applicable.

59 e applied to a clinically relevant real-time human herpes virus type 6 (HHV6) PCR assay that used a m

60 leukemia/lymphoma virus type 2 (HTLV-2), and human herpes virus type 8 (HHV-8) genomes.

61 ron alpha (IFN-alpha) to induce apoptosis in Human Herpes Virus Type 8 (HHV-8) positive Primary Effus

62 Infection with human herpes virus type 8 (HHV8), a B cell lymphotrophic

63 onic infections such as Helicobacter pylori, human herpes virus type 8 and cytomegalovirus.